2012

26/04/12
Stallergenes continues its strategic international expansion with the successful registration in Canada of Oralair™ tablet for grass pollen

Stallergenes SA (Euronext Paris CAC small) announced today that Health Canada has approved Oralair™. Oralair™ is a sublingual grass pollen immunotherapy tablet for the treatment of moderate to severe seasonal grass pollen...